Prostate Cancer Urology
Sep 24, 2024
The following is a summary of “Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis,” published in the September 2024 issue of Urology b...
Sep 20, 2024
The following is a summary of “Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial,” published in...
Aug 31, 2024
The following is a summary of “To Hold or Continue Blood Thinners? A Retrospective Analysis on Outcomes of Holmium Laser Enucleation of the Prostate (HoLEP) in Patients who Either Held or Continued ...
May 21, 2024
For patients with locally advanced prostate cancer, neoadjuvant chemohormonal therapy (NCHT) is beneficial for biochemical progression-free survival (bPFS), according to a study published in The Jour...
Mar 05, 2024
Digital rectal examination (DRE) exhibits low diagnostic value as an independent test and supplementary measure to prostate-specific antigen (PSA) for detection of prostate cancer, according to a stud...
Mar 05, 2024
Among patients with prostate cancer, greater consumption of plant-based foods is associated with higher scores in quality-of-life domains, according to a study published in Cancer. Stacy Loeb, MD, PhD...
Feb 12, 2024
Prostate cancer is the most common malignancy in men and remains one of the most prevalent and least understood of all human malignancies. Bladder cancer is the most frequently diagnosed cancer in Chi...
Jan 15, 2024
Some worry that physician practices acquired by private equity may increase the use of services to maximize revenue. We assessed the effects of private equity acquisition on spending, use of treatment...
Jan 05, 2024
At any given prostate-specific antigen (PSA) level, Black men were more likely than White men to develop prostate cancer, according to a study published in Cancer. Kyung Min Lee, PhD, and colleagues p...
Oct 09, 2023
Management of men with advanced prostate cancer has evolved to include urologists, made possible by oral targeted agents (eg, abiraterone or enzalutamide) that can be dispensed directly to patients in...
Aug 03, 2023
Study results indicate that family history of hereditary cancer syndrome appears to increase the risk for prostate cancer progression. Family history (FH) of malignancies, such as breast, ovari...
May 30, 2023
Christopher DiBlasio, MD, board-certified urologist and urologic surgeon, spoke with Physician’s Weekly about PMSA PET, an effective and precise technology for localizing metastatic prostate cancer....
May 08, 2023
We examine changes in the volume of patients with advanced prostate cancer and prescriptions for abiraterone and enzalutamide among urology practices with and without in-office dispensing.Using data f...
Jan 04, 2023
1. Fewer instances of clinically insignificant prostate cancer were identified in an experimental group receiving prostate MRI and targeted biopsy 2. Severe adverse events rare in both groups ...
Dec 19, 2022
Following a prostate cancer diagnosis, disease and treatment-related symptoms may result in diminished quality of life (QoL). Whether exercise improves QoL in men with metastatic castrate-resistant pr...
Dec 05, 2022
The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...
Dec 05, 2022
The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...
Dec 05, 2022
The objective of our study was to evaluate the detection rate of prostate cancer by digital rectal examination (DRE) and serum prostate-specific antigen (PSA) levels followed by standard 12-core trans...
Jul 20, 2022
The IsoPSA biomarker displays superior diagnostic accuracy in the early detection of prostate cancer, thereby helping to avoid unnecessary prostate biopsies. There is a growing population of pa...
Mar 07, 2022
Current therapeutic developments in prostate cancer (PCa) tend to increasingly personalize the treatment strategy, in particular as a function of tumor genomics. Recently, poly ADP-ribose polymerase (...